Recent share performance and business profile

Hercules Capital (HTGC) has traded around $15.57 recently, with the stock up about 2.3% on the latest day and modestly higher over the past week, while down roughly 6% over the past month.

Over the past 3 months, the stock is up about 4.8%, while year to date it is down roughly 17.4% and about 2.5% lower over the past year on a total return basis.

For a longer view, Hercules Capital shows total returns of roughly 42.5% over the past 3 years and about 57.9% over the past 5 years, which can help you compare it with other income focused vehicles.

The company reports revenue of about $554.5 million and net income of roughly $329.1 million, with annual revenue growth of 7.5% and net income growth of 8.7%, reflecting how its lending and investment activities have evolved.

Hercules Capital operates as a business development company focused on providing private equity, venture debt, and growth capital to venture backed and select public companies, mainly in technology, life sciences, sustainable and renewable technology, and related sectors.

The lending portfolio is concentrated in structured debt with warrants, senior debt, and some equity investments, with deal sizes that can range from $1 million to $500 million, giving investors exposure to a diversified pool of growth oriented borrowers.

With a market cap near $2.8 billion and a value score of 6, the stock sits in the mid cap range for BDCs. Its single reported business revenue segment, Lending and Investment, accounts for the full $554.5 million of revenue.

At a share price of $15.57, Hercules Capital has seen short term momentum cool after a 1 day share price gain of 2.3%. The year to date share price return is down 17.4%, while the 5 year total shareholder return of 57.9% points to a stronger longer term outcome.

Given that Hercules lends to high growth sectors like technology and life sciences, some of the recent share price pressure and the 1 year total shareholder return decline of 2.5% likely reflects changing sentiment on risk around these borrowers rather than any single company specific headline.

If Hercules has you thinking about where else growth capital might flow next, it is worth scanning opportunities in companies enabling AI infrastructure through the 48 AI infrastructure stocks

With Hercules Capital trading at $15.57 alongside an indicated 40% intrinsic discount and a 24% gap to analyst targets, the key question is whether this gap signals an opportunity or simply reflects the market already pricing in future growth.

Most Popular Narrative: 19.6% Undervalued

With Hercules Capital last closing at $15.57 versus a narrative fair value of $19.36, the current pricing sits well below what the most followed narrative implies.

The analysts have a consensus price target of $19.36 for Hercules Capital based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $25.0, and the most bearish reporting a price target of just $15.0.

Curious what kind of revenue build, margin profile, and future earnings multiple are included in that $19.36 figure? The narrative relies on detailed growth paths, a specific discount rate, and a tighter earnings forecast window that could surprise you once you see the full assumptions.

Result: Fair Value of $19.36 (UNDERVALUED)

However, the picture could change quickly if competition in venture lending squeezes yields or if tech and life sciences borrowers face a tougher credit cycle.

Next Steps

Does the mix of risks and rewards around Hercules Capital feel finely balanced to you, or skewed one way? Act while the details are fresh and review the 1 or more risks that investors are focused on and the 1 or more rewards that are supporting the thesis by checking out the 5 key rewards and 2 important warning signs.

Looking for more investment ideas?

If Hercules Capital has sharpened your thinking, do not stop here. Use the screener to surface other stocks that might better fit your goals.

• Target stability first by scanning companies with consistently robust finances through the solid balance sheet and fundamentals stocks screener (46 results).
• Hunt for potential value opportunities by reviewing companies flagged as 46 high quality undervalued stocks.
• Spot potential income ideas by checking out 10 dividend fortresses before yields move on without you.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.